NL8600112A - Immuno-regulator. - Google Patents

Immuno-regulator. Download PDF

Info

Publication number
NL8600112A
NL8600112A NL8600112A NL8600112A NL8600112A NL 8600112 A NL8600112 A NL 8600112A NL 8600112 A NL8600112 A NL 8600112A NL 8600112 A NL8600112 A NL 8600112A NL 8600112 A NL8600112 A NL 8600112A
Authority
NL
Netherlands
Prior art keywords
camosine
reaction
immuno
mouse
pfc
Prior art date
Application number
NL8600112A
Other languages
English (en)
Dutch (nl)
Original Assignee
Univ Nihon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nihon filed Critical Univ Nihon
Publication of NL8600112A publication Critical patent/NL8600112A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NL8600112A 1985-02-13 1986-01-20 Immuno-regulator. NL8600112A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2549485 1985-02-13
JP60025494A JPS61186322A (ja) 1985-02-13 1985-02-13 免疾調節剤

Publications (1)

Publication Number Publication Date
NL8600112A true NL8600112A (nl) 1986-09-01

Family

ID=12167607

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8600112A NL8600112A (nl) 1985-02-13 1986-01-20 Immuno-regulator.

Country Status (9)

Country Link
US (1) US4717716A (fr)
JP (1) JPS61186322A (fr)
CH (1) CH666188A5 (fr)
DE (1) DE3540632A1 (fr)
DK (1) DK171288B1 (fr)
FR (1) FR2577138B1 (fr)
GB (1) GB2170707B (fr)
NL (1) NL8600112A (fr)
SE (1) SE466787B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6314728A (ja) * 1986-07-03 1988-01-21 Zeria Shinyaku Kogyo Kk 肝障害の予防、治療剤
US4942530A (en) * 1987-03-02 1990-07-17 Mazda Motor Corporation Control of vehicle automatic transmission
US5110600A (en) * 1988-01-25 1992-05-05 The Regents Of The University Of California Method of treating viral infections with amino acid analogs
JPH0235057A (ja) * 1988-04-26 1990-02-05 Kinuko Nagai 機能性食品
JPH0717505B2 (ja) * 1989-02-23 1995-03-01 絹子 永井 骨粗鬆症予防剤
US5795859A (en) * 1991-07-05 1998-08-18 Peptide Technology Limited Peptide which abrogates TNF and/or LPS toxicity
ATE191147T1 (de) * 1991-07-26 2000-04-15 Commw Scient Ind Res Org System der bereitstellung eines impfstoffes auf peptidbasis, das sein eigenes adjuvans bildet, und seine herstellung
WO1993004690A1 (fr) * 1991-09-09 1993-03-18 Peptide Technology Limited Procede de traitement de complications liees au diabete et de la pathologie du diabete
AU660047B2 (en) * 1991-09-09 1995-06-08 King's College London Method for the treatment of the complications and pathology of diabetes
DE4307983A1 (de) * 1993-03-13 1994-09-15 Beiersdorf Ag Wirkstoffe und kosmetische und dermatologische Zubereitungen
RU2058553C1 (ru) * 1994-03-18 1996-04-20 Иван Николаевич Головистиков Способ определения супрессорного звена иммунного статуса человека
RU2056852C1 (ru) * 1994-03-18 1996-03-27 Иван Николаевич Головистиков Средство для лечения аутоиммунных заболеваний с иммунодефицитом супрессоров и способ лечения аутоиммунных заболеваний
US5576287A (en) * 1994-04-29 1996-11-19 Wake Forest University Method for treating acute renal disease and failure
KR960010020A (ko) 1994-09-09 1996-04-20 도리이 신이치로 조혈 기능 항진제
JPH0881371A (ja) * 1994-09-09 1996-03-26 Suntory Ltd 造血機能亢進剤
JP3877807B2 (ja) * 1996-07-03 2007-02-07 ゼリア新薬工業株式会社 口内炎治療・予防剤
JPH1029939A (ja) * 1996-07-17 1998-02-03 Zeria Pharmaceut Co Ltd 創傷治癒促進剤
WO2009046846A2 (fr) * 2007-09-11 2009-04-16 Mondobiotech Laboratories Ag Utilisation d'un peptide en tant qu'agent thérapeutique
IT1391251B1 (it) * 2008-10-15 2011-12-01 Innovative Nutrition & Pharma Srl Composizione per il trattamento delle patologie articolari
JP2012219080A (ja) * 2011-04-12 2012-11-12 Anbas:Kk 経口投与により腫瘍の発生又は増殖を抑止する組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4446149A (en) * 1981-12-14 1984-05-01 Kineshiro Nagai Medicine for treatment of cervical erosion
JPS6016934A (ja) * 1983-07-06 1985-01-28 Kaneshiro Nagai 抗腫瘍剤

Also Published As

Publication number Publication date
SE466787B (sv) 1992-04-06
SE8505121D0 (sv) 1985-10-30
DE3540632A1 (de) 1986-08-21
GB2170707A (en) 1986-08-13
GB8527243D0 (en) 1985-12-11
DE3540632C2 (fr) 1992-09-17
FR2577138B1 (fr) 1990-06-22
JPS61186322A (ja) 1986-08-20
DK500585A (da) 1986-08-14
FR2577138A1 (fr) 1986-08-14
US4717716A (en) 1988-01-05
DK500585D0 (da) 1985-10-31
CH666188A5 (de) 1988-07-15
DK171288B1 (da) 1996-08-26
GB2170707B (en) 1989-02-15
JPH0481966B2 (fr) 1992-12-25
SE8505121L (sv) 1986-08-14

Similar Documents

Publication Publication Date Title
NL8600112A (nl) Immuno-regulator.
US4778788A (en) Agent against multiple sclerosis
JPS62116510A (ja) 神経再生のための新規な医薬組成物
ZA200105275B (en) New use of melagatran.
US3966944A (en) 10 (N-methyl-4-piperidylidene)-10H[1]-benzopyrano[3,2-b]-pyridine as an analgesic, anti-inflammatory and agent against type III hypersensitivity disease
US4107331A (en) Zinc chelating fungicidal composition
WO2001012204A2 (fr) Compositions et procede de traitement de l'intoxication a l'acetaminophene
US4914121A (en) 3-Phenyl-1-phenylpyrazole-4 acetic acid compounds which are useful in treating immune diseases
Dewey et al. Treatment of a myasthenic dog with mycophenolate mofetil
US4994492A (en) Treatment of melanoma using N,N-dimethylglycine
JPH0641411B2 (ja) 免疫調節剤
JPH07165582A (ja) 免疫抗癌剤の抗癌効果増強剤
US4348407A (en) Orally active tolciclate and tolnaftate
GB2078516A (en) Pharmaceutical compositions containing arginine and lysine
JP2002536337A (ja) 麻酔の調節
Keeton Ammonia excretion following experimental administration of acids via the stomach and peripheral vein.
JP2627914B2 (ja) プロスタグランジン類の選択的作用増強剤
JPH03504506A (ja) 蠕虫感染症の治療または予防用の医薬および動物薬組成物
JP3233933B2 (ja) 内毒素ショック抑制化合物とその使用方法
JPH061721A (ja) 疼痛処置剤、及び疼痛軽減作用増強剤
JPS6354686B2 (fr)
Kikuchi et al. Effect of prostaglandin E1 on experimental acute hepatic failure in rabbits: prostaglandin E1 prevents the development of multiple-organ failure
USRE32145E (en) Orally active tolciclate .[.(and tolnaftate).].
AU634386B2 (en) Treatment of horses using ethylestrenol
Robinson Toxicity and pharmacology of cycloserine

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed